F-STAR BIOTECHNOLOGY

Unknown (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£149,994

Mar 13 - Aug 14

DEVELOPMENT FEASIBILITY OF A NOVEL SUPERIOR HER2-SPECIFIC TARGETED DRUG CONJUGATE FOR CANCER THERAPY

Innovate UK award to F-STAR BIOTECHNOLOGY

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}